Pharmacogenetics of morphine: Potential implications in sickle cell disease by Darbari Deepika S, Minniti Caterina P, Rana Sohail, van den Anker John in American journal of hematology (2008).

[PMID: 17722074] PubMed


Morphine is frequently used to treat painful episodes associated with sickle cell disease (SCD) but may fail to provide adequate analgesia in many patients. This concise review focuses on unique disease related changes in physiologic variables associated with SCD that impacts pharmacokinetics and pharmacodynamics of morphine and may contribute to the variability in analgesia. Emerging evidence suggests that the allelic variants in the genes involving the opioid (UGT2B7, OPRM1, and ABCB1 genes) and nonopioid system (COMT gene) can alter the efficacy of morphine.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.